S-Biomedic
About S-Biomedic
S-Biomedic brings novel therapeutic solutions to the skin microbiome.The skin microbiome - a habitat of billions of beneficial and harmful bacteria - contributes to healthy skin. An imbalance of these bacteria can lead to a variety of skin conditions including acne, eczema, rosacea and ageing. S-Biomedic uses a targeted modulation-based technology to modify the skin microbiome. This technology can be applied in both the dermatology and cosmetic industries. They design their products using the latest advances in microbiology and dermatology. Using their technology, beneficial bacteria are selected and combined to generate products that accelerate the rebalancing of a disease microbiome. In this way, they are able to restore a healthy state back to your skin.
Company Metrics
- Employees: 1-10
- Monthly Visits: None
- Tech Stack: 17 active products
Financial Information
- Estimated Revenue: Less than $1M
- Total Funding: 4000000 EUR
- Last Funding: 4000000 EUR (Series A)
- Funding Status: M&A
Technology Stack
S-Biomedic actively uses 17 products in their tech stack.
Market Presence
Industries: Biotechnology, Health Care
Headquarters: Belgium, Wisconsin, United States